| Barfield Health Care | |
| 22444 Highway 431, Guntersville, Alabama 35976 | |
| (256) 582-3112 | |
| Name | Barfield Health Care |
|---|---|
| Location | 22444 Highway 431, Guntersville, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 113 |
| Occupancy Rate | 88.32% |
| Medicare ID (CCN) | 015225 |
| Legal Business Name | Barfield Health Care Acquisition Corporation |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1124015292 |
| Organization Name | BARFIELD HEALTH CARE, INC. |
| Address | 22444 Us Highway 431, Guntersville, AL 35976 |
| Phone Number | 256-582-3112 |
News Archive
In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.
Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells - knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.
› Verified 6 days ago
| NPI Number | 1528558855 |
| Organization Name | BARFIELD HEALTH CARE ACQUISITION CORPORATION |
| Doing Business As | BARFIELD HEALTH CARE |
| Address | 22444 Us Highway 431, Guntersville, AL 35976 |
| Phone Number | 256-582-3112 |
News Archive
In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.
Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells - knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.
Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells - knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.5 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.44 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.05 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.62 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.86 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 2.17 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.69 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.21 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.93 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 87.76 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.52 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 10.96 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.37 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.61 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.82 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 53.78 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.18 | 82.93 |
News Archive
In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.
Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells - knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor takeover by more dangerous, receptor-negative cells.
› Verified 6 days ago
Marshall Manor Nursing Home Location: 3120 North Street, Guntersville, Alabama 35976 Phone: (256) 582-6561 |